EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel HDAC6 Inhibitor Ameliorates Imiquimod-Induced Psoriasis-Like Inflammation in Mice

Anqi Cao iD, Yurong Li iD, Yanqiao Feng, Xiaoquan Wang iD, Wenyu Wei, Hongyan Sun, Junmin Quan iD

Molecules · 2025

DOI: 10.3390/molecules30153224 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Anqi Cao und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Oncogenomics, Guangdong Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen 51…. Hauptthemen laut MEDLINE: Imiquimod, Psoriasis, Histone Deacetylase 6, Histone Deacetylase Inhibitors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Science and Technology Innovation Program, Shenzhen Fundamental Research Program, NSFC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriasis is a chronic inflammatory skin disease characterized by abnormal proliferation of keratinocytes and infiltration of inflammatory cells. Significant challenges remain in developing effective and safe targeted therapies for psoriasis. Here, we reported the discovery of novel cystamine derivatives for the treatment of psoriasis. These compounds effectively attenuated LPS-induced inflammation in vitro, and the optimal candidate CS1 ameliorated imiquimod-induced psoriasis-like inflammation in mice. Mechanistically, CS1 bound and inhibited the deacetylase HDAC6, subsequently inhibited the AKT, MAPK, and STAT3 pathways, attenuated the hyperproliferation and altered differentiation of keratinocytes and reduced the infiltration of immune cells. These findings suggest that HDAC6 may serve as a potential target for drug development in the treatment of psoriasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImiquimodPsoriasisHistone Deacetylase 6Histone Deacetylase InhibitorsInflammationAnimalsMiceHumansKeratinocytesDisease Models, AnimalSTAT3 Transcription FactorCell ProliferationSignal TransductionCell Differentiation

Stichwörter der Autor:innen

HDAC6MAPKSTAT3inflammationpsoriasis

Substanzen

ImiquimodHistone Deacetylase 6Histone Deacetylase InhibitorsHdac6 protein, mouseSTAT3 Transcription Factor

Autor:innen und Institutionen

  • State Key Laboratory of Chemical Oncogenomics, Guangdong Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen 518055, China.
  • Inno Biopharmaceuticals (Shenzhen) Co., Ltd., Shenzhen 518055, China.
  • State Key Laboratory of Efficient Utilization of Arable Land in China, the Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences, Beijing 100081, China.
  • Department of Chemistry and Center of Super-Diamond and Advanced Films (COSDAF), City University of Hong Kong, 83 Tat Chee Avenue, Kowloon, Hong Kong 999077, China.

ORCID-Profile: Anqi Cao, Yurong Li, Xiaoquan Wang, Junmin Quan

Förderung

  • Shenzhen Science and Technology Innovation Program
  • Shenzhen Fundamental Research Program
  • NSFC

Zitieren

APA

Cao, A., Li, Y., Feng, Y., Wang, X., Wei, W., Sun, H., & Quan, J. (2025). A Novel HDAC6 Inhibitor Ameliorates Imiquimod-Induced Psoriasis-Like Inflammation in Mice. Molecules. https://doi.org/10.3390/molecules30153224

Vancouver

Cao A, Li Y, Feng Y, Wang X, Wei W, Sun H, et al. A Novel HDAC6 Inhibitor Ameliorates Imiquimod-Induced Psoriasis-Like Inflammation in Mice. Molecules. 2025. doi:10.3390/molecules30153224

BibTeX
@article{Cao2025,
  author = {Cao, Anqi and Li, Yurong and Feng, Yanqiao and Wang, Xiaoquan and Wei, Wenyu and Sun, Hongyan and Quan, Junmin},
  title = {A Novel HDAC6 Inhibitor Ameliorates Imiquimod-Induced Psoriasis-Like Inflammation in Mice},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30153224}
}
Kostenlos starten →